Elevai Labs, Inc. (ELAB)
NASDAQ: ELAB · IEX Real-Time Price · USD
0.572
-0.026 (-4.35%)
At close: Jul 2, 2024, 3:59 PM
0.589
+0.017 (2.94%)
After-hours: Jul 2, 2024, 7:39 PM EDT
Elevai Labs Revenue
Elevai Labs had revenue of $2.18M in the twelve months ending March 31, 2024, with 147.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $614.56K with 330.31% year-over-year growth. In the year 2023, Elevai Labs had annual revenue of $1.71M with 123.50% growth.
Revenue (ttm)
$2.18M
Revenue Growth
+147.01%
P/S Ratio
4.95
Revenue / Employee
$121,352
Employees
18
Market Cap
10.81M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.71M | 946.32K | 123.50% |
Dec 31, 2022 | 766.28K | 765.45K | 92,557.44% |
Dec 31, 2021 | 827.00 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionELAB News
- 18 days ago - Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs - GlobeNewsWire
- 5 weeks ago - Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference - GlobeNewsWire
- 6 weeks ago - Elevai Labs Inc. Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity - GlobeNewsWire
- 2 months ago - Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare - GlobeNewsWire
- 2 months ago - Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments - GlobeNewsWire
- 2 months ago - Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments - GlobeNewsWire
- 2 months ago - ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months - GlobeNewsWire